SilkFusion 3D bioprinting with Cellink BioX

2018-11-20 News

Silkfusion H2020 Project work in progress. We are bioprinting the future of research on platelet production. Check it in this short video!

SilkFusion Newsletter Nº4: November 2020
INTERVIEW | Johana Macedo: “Turning an idea into something valuable for the market constitutes the principal objective in the framework of a European Project”
INTERVIEW | Hana Raslova: “One of the Silkfusion aims is to propose a personalized treatment for patients suffering of severe inherited thrombocytopenia”
INTERVIEW | Cedric Ghevaert: “The recent epidemic has shown the fragility of the platelet supply to hospital because it requires human donation”
INTERVIEW | Alessandra Balduini: “SilkFusion technology is especially exciting for researchers and clinicians by allowing them to conduct pharmacological studies on human cells”

Back

contact@silkfusion.eu

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767309

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More

Privacy & Cookies Policy